Literature DB >> 12873972

Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase.

Daoyan Wei1, Erica L Richardson, Keyi Zhu, Liwei Wang, Xiangdong Le, Yanjuan He, Suyun Huang, Keping Xie.   

Abstract

Inducible nitric oxide synthase (NOS) II expression can be induced in the tumor bed, predominantly in host cells that infiltrate and surround a tumor. However, the impact of this physiological NOS II expression in host cells on tumor growth and metastasis remains unclear because of a lack of appropriate experimental approaches. In the present study, three NOS II-null (NOS II(-/-)) tumor cell lines, KX-dw1, KX-dw4, and KX-dw7, were established and verified using Southern, Northern, and Western blot analysis, and nitric oxide production assays. Cells from these lines were then s.c. and i.v. injected into NOS II(+/+) and NOS II(-/-) C57BL/6 mice. NOS II protein expression and enzyme activity were clearly detected in the tumors that formed in NOS II(+/+) mice but not in those that formed in NOS II(-/-) mice. Consistent with the absence of NOS II expression in the tumor stroma, KX-dw1, KX-dw4, and KX-dw7 cells grew much faster and produced many more experimental lung metastases in NOS II(-/-) mice than in NOS II(+/+) mice. Therefore, physiological expression of NOS II in host cells directly inhibits tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873972

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Proteomic analysis of the NOS2 interactome in human airway epithelial cells.

Authors:  Matthew W Foster; J Will Thompson; Michael T Forrester; Yonggang Sha; Timothy J McMahon; Dawn E Bowles; M Arthur Moseley; Harvey E Marshall
Journal:  Nitric Oxide       Date:  2013-02-21       Impact factor: 4.427

2.  Evaluation of the interaction between TGF beta and nitric oxide in the mechanisms of progression of colon carcinoma.

Authors:  Sylvia Lohm; Lucie Peduto-Eberl; Patricia Lagadec; Nicole Renggli-Zulliger; Jean Dudler; Jean-François Jeannin; Lucienne Juillerat-Jeanneret
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 3.  Metabolic mechanisms of tumor resistance to T cell effector function.

Authors:  Candace M Cham; Thomas F Gajewski
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors.

Authors:  Xiangdong Le; Daoyan Wei; Suyun Huang; Jack R Lancaster; Keping Xie
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

Review 5.  Tumor-host interactions: the role of inflammation.

Authors:  Marie-Aude Le Bitoux; Ivan Stamenkovic
Journal:  Histochem Cell Biol       Date:  2008-10-25       Impact factor: 4.304

6.  Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.

Authors:  Jirí Svec; Peter Ergang; Václav Mandys; Milan Kment; Jirí Pácha
Journal:  Int J Exp Pathol       Date:  2010-02       Impact factor: 1.925

7.  Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.

Authors:  Douglas D Thomas; Michael Graham Espey; Lisa A Ridnour; Lorne J Hofseth; Daniele Mancardi; Curtis C Harris; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

Review 8.  Gasotransmitters in cancer: from pathophysiology to experimental therapy.

Authors:  Csaba Szabo
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

Review 9.  NO and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.

Authors:  Jian Wang; S Perwez Hussain
Journal:  Antioxid Redox Signal       Date:  2016-09-22       Impact factor: 8.401

Review 10.  Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Authors:  Jeff S Isenberg; Gema Martin-Manso; Justin B Maxhimer; David D Roberts
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.